Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models

VB-111 is an engineered antiangiogenic adenovirus that expresses Fas-c in angiogenic blood vessels and has previously been shown to have significant antitumor activity in vitro and in vivo in Lewis lung carcinoma, melanoma, and glioblastoma models. To evaluate the efficacy of VB-111 in thyroid cance...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Reddi, H. V., Madde, P., Cohen, Y. C., Bangio, L., Breitbart, E., Harats, D., Bible, K. C., Eberhardt, N. L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2011
Aiheet:
Short Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3374632/
https://ncbi.nlm.nih.gov/pubmed/22701765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601912437933
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia